
ISALT hosted its third annual forum, bringing together institutional investors, business leaders, government officials, and industry experts to explore how the dual-use industry can drive new economic growth, with innovation and industrial recovery at the heart of our strategic autonomy.
The Strategic Transitions Fund (FST), managed by ISALT, is leading a new round of funding for Oury Medical – a French industrial group specialising in orthopaedic and spinal medical instruments.
ISALT announces the nomination of Xavier Poitevineau and Ilan Rozenkopf as Managing Directors and co‑heads of its new Stratégie Horizon Dual (SHD) fund.
ISALT, through its Fonds Stratégique des Transitions (FST), announces its 8th investment in Meelo, a purpose-driven French company developing a SaaS platform to secure customer journeys, detect fraud, and predict payment default risk, powered by Open Banking, Open Data, and AI.












